Elodie Ghedin, Ph.D.
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Elodie Ghedin, Ph.D., leads the Systems Genomics Section at the Laboratory of Parasitic Diseases of NIAID/NIH in Bethesda, Md. She also holds an affiliation with New York University where she was director of the Center for Genomics and Systems Biology and professor of biology and global public health until May 2020. Before joining NYU, she was on the faculty of the Center for Vaccine Research and Department of Computational and Systems Biology at the University of Pittsburgh.
The overarching theme in the Ghedin Lab is based on defining host-pathogen interactions to understand their effects on health and disease. The research program meets at the interface of molecular virology, microbiology, systems biology and genomic epidemiology but also converges with data science, material physics and bioengineering to develop novel research frameworks for discovery. A large part of Elodie’s studies are on characterizing virus diversity—primarily influenza, and now SARS-CoV-2—within and across infected hosts, and on defining the interactions within the microbiome of the respiratory tract to understand the dynamics of virus transmission. Another part of her research is on how filarial worms (parasitic nematodes) adapt to niches in their human hosts. The goal is to identify novel druggable targets and discover new metabolites and immunomodulators with therapeutic potential.
Elodie obtained her B.Sc. and Ph.D. from McGill University, and an M.Sc. from UQAM, in Montreal, Canada. She is a MacArthur Foundation Fellow (2011), a Kavli Frontier of Science Fellow (2012), and an American Academy of Microbiology fellow (2017).
The overarching theme in the Ghedin Lab is based on defining host-pathogen interactions to understand their effects on health and disease. The research program meets at the interface of molecular virology, microbiology, systems biology and genomic epidemiology but also converges with data science, material physics and bioengineering to develop novel research frameworks for discovery. A large part of Elodie’s studies are on characterizing virus diversity—primarily influenza, and now SARS-CoV-2—within and across infected hosts, and on defining the interactions within the microbiome of the respiratory tract to understand the dynamics of virus transmission. Another part of her research is on how filarial worms (parasitic nematodes) adapt to niches in their human hosts. The goal is to identify novel druggable targets and discover new metabolites and immunomodulators with therapeutic potential.
Elodie obtained her B.Sc. and Ph.D. from McGill University, and an M.Sc. from UQAM, in Montreal, Canada. She is a MacArthur Foundation Fellow (2011), a Kavli Frontier of Science Fellow (2012), and an American Academy of Microbiology fellow (2017).